Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
14.77
-0.18 (-1.20%)
At close: Oct 17, 2025, 4:00 PM EDT
14.80
+0.03 (0.20%)
Pre-market: Oct 20, 2025, 8:32 AM EDT
Xencor Market Cap
Xencor has a market cap or net worth of $1.05 billion as of October 20, 2025. Its market cap has decreased by -12.45% in one year.
Market Cap
1.05B
Enterprise Value
562.13M
1-Year Change
-12.45%
Ranking
Category
Stock Price
$14.77
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $1.05B, an increase of 329.28%. That is a compound annual growth rate of 13.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.05B | -34.50% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
| Dec 3, 2013 | 245.40M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |